Peptide-based cationic liposome-mediated gene delivery

Expert Opinion on Drug Delivery

Volumn 9, Issue 1, 2012, Pages 127-139

  Zhao, Yinan ^a,b   Zhang, Shubiao ^a   Cui, Shaohui ^a   Wang, Bing ^a   Zhang, Shufen ^b  

^a DALIAN NATIONALITIES UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Gemini lipids; Gene delivery; Lipitoids; Liposomes; Peptide cationic lipids

Indexed keywords

CHOLESTEROL; DRUG CARRIER; LIPID; LIPITOID; LIPOSOME; PEPTIDE; UNCLASSIFIED DRUG;

CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG DESIGN; DRUG TARGETING; GENE VECTOR; HYDROPHOBICITY; LIPOSOMAL GENE DELIVERY SYSTEM; PROTEIN MODIFICATION; REVIEW; VECTOR CONTROL;

ANIMALS; CATIONS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HUMANS; LIPIDS; LIPOSOMES; MOLECULAR STRUCTURE; PEPTIDES; PROTEIN CONFORMATION;

EID: 84255171273     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.630387     Document Type: Review

References (85)

1. Crystal RG. Transfer of genes to human: early lessons and obstacles to success. Science 1995;270:148-51
2. Donahue RE, Kessler SW, Bodine D, et al. Helper virus induced T cell lymphoma in nonhuman primates afrer retrovira mediated gene transfer. J Exp Med 1992;176:1125-35
3. Sun JY, Anand-Jawa V, Chatterjee S, et al. Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther 2003;10:964-76 (Pubitemid 36722431)
4. Boktov J, Hirsch-Lerner D, Barenholz Y. Characterization of the interplay between the main factors contributing to lipoplex-mediated transfection in cell cultures. J Gene Med 2007;9:884-93 (Pubitemid 47543255)
5. Hyde SC, Southern KW, Gileadi U, et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 2000;7:1156-65 (Pubitemid 30458808)
6. Noone PG, Hohneker KW, Zhou Z, et al. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther 2000;1:105-14
7. Stopeck AT, Jones A, Hersh EM, et al. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex,in patients with, metastatic metastatic melanoma. Clin Cancer Res 2001;7:2285-91 (Pubitemid 32751626)
8. Ferber D. Gene therapy: safer and virus-free. Science 2001;294:1638-42
9. Hacein-Bey-Abina S, Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X linked severe combined immunodeficiency. N Engl J Med 2003;348:255-6 (Pubitemid 36077924)
10. Woods NB, Bottero V, Schmidt M, et al. Gene therapy: therapeutic gene causing lymphoma. Nature 2006;440:1123-34
11. Arpicco S, Canevari S, Ceruti M, et al. Synthesis characterization and transfection activity of new saturated and unsaturated cationic lipids. Il Farmaco 2004;59:869-78 (Pubitemid 39488367)
12. Bianco A, Bonadies F, Napolitano R, et al. A simple approach to DC-cholesterol, its analogues and vitamin D-based cationic lipids for gene therapy. Lett Org Chem 2005;2:79-82
13. Zhang SB, Zhao YN, Zhao BD, et al. Hybrids of nonviral vectors for gene delivery. Bioconjug Chem 2010;21:1003-9
14. Rea JC, Gibly RF, Barron AE, et al. Self-assembling peptide-lipoplexes for substrate-mediated gene delivery. Acta Biomater 2009;5:903-12
15. Coles DJ, Esposito A, Chuah HT, et al. The synthesis and characterization of lipophilic peptide-based carriers for gene delivery. Tetrahedron 2010;66:5435-41
16. Zhang SB, Xu YM, Wang B, et al. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release 2004;100:165-80 (Pubitemid 39491269)
17. Ko YT, Falcao C, Torchilin VP. Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK) 2 and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy. Mol Pharm 2009;6:971-7
18. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009;109:259-302
19. Nishikawa M, Yamauchi M, Morimoto K, et al. Heptocyte-targeted in vivo gene expression by intraveneous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther 2000;7:548-55 (Pubitemid 30175557)
20. Schuster MJ, Wu GY, Walton CM, et al. Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhaances liver-targeted gene expression in mice. Bioconjug Chem 1999;10:1075-83
21. McKenzie DL, Kwok KY, Rice KG. A potent new class of reductively activated peptide gene delivery agents. J Biol Chem 2000;275:9970-7 (Pubitemid 30202043)
22. Brizard A, Dolain C, Huc I, et al. Asp-Gly based peptides confined at the surface of cationic Gemini surfactant aggregates. Langmuir 2006;22:3591-600 (Pubitemid 43672527)
23. Huang CY. UnoT, Murphy JE, et al. Lipitoids-novel cationic lipids for cellular delivery of plasmid DNA in vitro. Chem Biol 1998;5:345-54 (Pubitemid 28309988)
24. Choi JS, Lee EJ, Jang HS, et al. New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity. Bioconjug Chem 2001;12:108-13
25. Sochanik A, Kaida I, Mitrus I, et al. A new cholesterol derivative suitable for transfecting certain type of cells in the presence of 10% serum. Cancer Gene Ther 2000;7:513-20 (Pubitemid 30326885)
26. Obata Y, Daisuke S, Shinji T. Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. Bioconjug Chem 2008;19:1055-63 (Pubitemid 351748314)
27. Prata Carla AH, Zhang XX, Luo D, et al. Lipophilic peptides for gene delivery. Bioconjug Chem 2008;19:418-20 (Pubitemid 351294912)
28. Ma BC, Zhang SB, Jiang HM, et al. Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release 2007;1111:184-94
29. Niculescu-Duvaz D, Heyes J, Springer CJ. Structure-activity relationship in cationic lipid mediated gene transfection. Curr Med Chem 2003;10:1233-61 (Pubitemid 36763933)
30. Zhao YN, Zhang SB, Cui SH. The development of polypeptide cationic liposome. Chem World 2010;11:701-7
31. Gao X, Huang L. A novel cationic liposome reagent for efficiency transfection of mammalian cells. Biochem Biophys Res Commun 1991;179:280-5
32. Aissaoui A, Oudrhiri N, Petit L, et al. Progress in gene delivery by cationic lipids: guanidinium-cholesterol-based systems as an example. Curr Drug Targets 2002;3:1-16 (Pubitemid 34296301)
33. Fujiwara T, Hasegawa S, Hirashima N, et al. Gene transfection activities of amphiphilic steroid-polyamine conjugates. Biochim Biophys Acta Biomembr 2000;1468:396-402
34. Heyes J, Palmer L, Chan K, et al. Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA. Mol Ther 2005;15:713-20
35. Wasungu L, Stuart MC, Scarzello M, et al. Lipoplexes formed from sugar-based Gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes. Biochim Biophys Acta 2006;1758:1677-84 (Pubitemid 44466704)
36. Pastorino F, Mumbengegwi DR, Ribatti D, et al. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin. J Control Release 2008;126:85-94
37. Tagami T, Hirose K, Barichello JM, et al. Global gene expression profiling in cultured cells is Strongly influenced bytreatment with siRNA-cationic liposome complexes. Pharm Res 2008;25:2497-504
38. Han SE, Kang H, Shim GY, et al. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Int J Pharm 2008;353:260-9
39. Felgner P, Gadek T, Holm M, et al. Lipofectin: a highly efficient, lipid mediated DNA-transfection procedure. Proc Natl Acad Sci 1987;84:7413-17
40. Gebeyehu G, Jessee JA, Ciccarone VC, et al. New dihydroxypropyl alkylene diand poly- amine cationic lipids for conjugation with reporter molecules, DNA, or drugs, for assay, enhanced targetting, and transfection of cells. U.S. Patent 1994;5:334,761
41. Bennett CF, Chiang MY, Chan H, et al. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 1992;41:1023-33 (Pubitemid 23026100)
42. Wang CY, Huang L. Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. Biochemistry 1989;28:9508-14 (Pubitemid 20000730)
43. Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta Biomembr 1994;1189:195-203 (Pubitemid 24042719)
44. Xu Y, Szoka FC. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996;35:5616-23 (Pubitemid 26143656)
45. Zelphati O, Szoka FC. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci USA 1996;93:11493-8 (Pubitemid 26347149)
46. Uyechi-OBrien LS, Szoka FC. Mechanisms for cationic lipids in gene transfer. Drugs Pharm Sci 2003;131:79-108
47. Li W, Szoka FC. Lipid-based Nanoparticles for Nucleic Acid Delivery. Pharm Res 2007;24:438-49 (Pubitemid 46295166)
48. Bergen JM, Kwon EJ, Shen TW, et al. Application of an environmentallysensitive fluorophore for rapid analysis of the binding and internalization efficiency of gene carriers. Bioconjug Chem 2008;19:377-84 (Pubitemid 351213873)
49. Akinc A, Langer R. Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. Biotechnol Bioeng 2002;78:503-8 (Pubitemid 34727946)
50. Bieber T, Meissner W, Kostin S, et al. Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J Control Release 2002;82:441-54
51. Itaka K, Harada A, Yamasaki Y, et al. In situ single cell observation by fluorescence resonance energy transfer reveals fast intracytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J Gene Med 2004;6:76-84 (Pubitemid 40228005)
52. Grosse S, Thevenot G, Monsigny M, et al. Which mechanism for nuclear import of plasmid DNA complexed with polyethylenimine derivatives? J Gene Med 2006;8:845-51 (Pubitemid 44097140)
53. Vaughan EE, DeGliulio JV, Dean DA. Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import. Curr Gene Ther 2006;6:671-81 (Pubitemid 44890549)
54. Vacik J, Dean BS, Zimmer WE, et al. Cell-specific nuclear import of plasmid DNA. Gene Ther 1999;6:1006-14 (Pubitemid 29295205)
55. Huth S, Hoffmann F, Gersdorff K, et al. Interaction of polyamine gene vectors with RNA leads to the dissociation of plasmid DNA-carrier complexes. J Gene Med 2006;8:14116-24
56. Folda T, Gros L, Ringsdorf H. Formation of oriented polypeptides and polyamides in monolayers and liposomes. Makromol Chem Rapid Commun 1982;3:167-74
57. Neumann R, Ringsdorf H. Peptide liposomes from amphiphilic amino acids. J Am Chem Soc 1986;108:487-90 (Pubitemid 16160694)
58. Kim HS, Moon J, Kim KS, et al. Gene-transferring efficiencies of novel diamino cationic lipids with varied hydrocarbon chain. Bioconjug Chem 2004;15:1095-101 (Pubitemid 39297833)
59. Kim HS, Song IH, Kim JC, et al. In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD O, O-dimyristyl-N-lysyl glutamate. J Control Release 2006;115:234-41 (Pubitemid 44537502)
60. Rasmussen FW, Bendifallah N, Zachar V, et al. Evaluation of transfection protocols for unmodified and modified peptide nucleic acid (PNA) oligomers. Oligonucleotides 2006;16:43-57
61. Bendifallah N, Rasmussen FW, Zachar V, et al. Evaluation of cellpenetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjug Chem 2006;17:750-8 (Pubitemid 43794386)
62. Shiraishi T, Pankratova S, Nielsen PE. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. Chem Biol 2005;12:923-9 (Pubitemid 41206806)
63. Turner JJ, Ivanova GD, Verbeure B, et al. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Res 2005;33:6837-49 (Pubitemid 43000315)
64. Boe S, Longva AS, Hovig E. Photochemically induced gene silencing using small interfering RNA molecules in combination with lipid carriers. Oligonucleotides 2007;17:166-73 (Pubitemid 47124414)
65. Shiraishi T, Nielsen PE. Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates. FEBS Lett 2006;580:1451-6 (Pubitemid 43222014)
66. Koppelhus U, Shiraishi T, Zachar V, et al. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (catlip) domain. Bioconjug Chem 2008;19:1526-34
67. Obata Y, Saito S, Takeda N, et al. Plasmid DNA-encapsulating liposomes: effect of a spacer between the cationic head group and hydrophobic moieties of the lipids on gene expression efficiency. Biochem Biophys Acta 2009;1788:1148-58
68. Obata Y, Ciofani G, Raffa V, et al. Evaluation of cationic liposomes composed of an amino acid-based lipid for neuronal transfection. Nanomedicine Nanotechnol Biol Med 2010;6:70-7
69. Cashion MP, Li XL, Geng Y, et al. Gemini surfactant electrospun membranes. Langmuir 2010;26:678-83
70. Bhattacharya S, De S, George SK. Synthesis and vesicle formation from novel pseudoglyceryl dimeric lipids. Chem Commun 1997;23:2287-8
71. Camilleri P, Kremer A, Edwards AJ, et al. A novel class of cationic Gemini surfactants showing efficient in vitro gene transfection properties. Chem Commun 2000;14:1253-4 (Pubitemid 30484201)
72. McGregor C, Perrin C, Monck M, et al. Rational approaches to the design of cationic Gemini surfactants for gene delivery. J Am Chem Soc 2001;123:6215-20 (Pubitemid 32904647)
73. Buijnsters PJJA, Rodriguez CLG, Willighagen EL, et al. Cationic Gemini surfactants based on tartaric acid: synthesis,aggregation, monolayer behaviour, and interaction with DNA. Eur J Org Chem 2002;8:1397-406
74. Brito RO, Marques EF, Gomes P, et al. Self-assembly in a catanionic mixture with an aminoacid-derived surfactant: from mixed micelles to spontaneous vesicles. J Phys Chem 2006;110:18158-65 (Pubitemid 44547317)
75. Kwon YU, Kodadek TJ. Quantitative Evaluation of the Relative Cell Permeability of Peptoids and Peptides. Am Chem Soc 2007;129:1508-9
76. Wrenn SJ, Weisinger RM, Halpin DR, et al. Contribution from the Department of Biochemistry and the Department of Chemistry. Am Chem Soc 2007;129:13137-43
77. Udugamasooriya DG, Dineen SP, Brekken RA, et al. A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity. Am Chem Soc 2008;130:5744-52 (Pubitemid 351600507)
78. Yoo B, Kirshenbaum K. Peptoid architectures: elaboration, actuation, and application. Curr Opin Chem Bio 2008;12:714-21
79. Lu XW, Zeng Y, Liu CF. Modulating the hybridization property of PNA with a peptoid-like side chain. Org Lett 2009;11:2329-32
80. Utku Y, Dehan E, Ouerfelli O, et al. A peptidomimetic siRNA transfection reagent for highly effective gene silencing. Mal Biosyst 2006;2:312-17 (Pubitemid 43882753)
81. Seurynck-Servoss SL, Dohm MT, Barron AE. Effects of including an N-terminal insertion region and arginine-mimetic side chains in helical peptoid analogues of lung surfactant protein B. Biochemistry 2006;45:11809-18 (Pubitemid 44497808)
82. Dohm MT, Brown NJ, Seurynck-Servoss SL, et al. Mimicking SP-C palmitoylation on a peptoid-based SP-B analogue markedly improves surface activity. Biochim Biophys Acta 2010;1798:1663-78
83. Ren T, Zhang GS, Liu F, et al. Synthesis and evaluation of vitamin D-based cationic lipids for gene delivery in vivo. Bioorg Med Chem Lett 2000;10:891-4 (Pubitemid 30301587)
84. Xu L, Anchordoquy TJ. Cholesterol domains in cationic lipid/DNA complexes improve transfection. Biochim Biophys Acta 2008;1778:2177-81
85. Wang D, Lin QS. Cationic liposome mediated gene transfer. Pro Biochem biophys 1997;24:486-92